ATE138200T1 - Das von mca-28a32 erkannte antigen - Google Patents

Das von mca-28a32 erkannte antigen

Info

Publication number
ATE138200T1
ATE138200T1 AT91909273T AT91909273T ATE138200T1 AT E138200 T1 ATE138200 T1 AT E138200T1 AT 91909273 T AT91909273 T AT 91909273T AT 91909273 T AT91909273 T AT 91909273T AT E138200 T1 ATE138200 T1 AT E138200T1
Authority
AT
Austria
Prior art keywords
epitope
mca
antigen
human
antigen recognized
Prior art date
Application number
AT91909273T
Other languages
English (en)
Inventor
Nicholas Pomato
Ebo Sybren Bos
Janet Hazel Ransom
Michael George Hanna
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE138200T1 publication Critical patent/ATE138200T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
AT91909273T 1990-04-12 1991-04-10 Das von mca-28a32 erkannte antigen ATE138200T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50837390A 1990-04-12 1990-04-12

Publications (1)

Publication Number Publication Date
ATE138200T1 true ATE138200T1 (de) 1996-06-15

Family

ID=24022500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909273T ATE138200T1 (de) 1990-04-12 1991-04-10 Das von mca-28a32 erkannte antigen

Country Status (12)

Country Link
EP (1) EP0537168B1 (de)
JP (1) JPH05507470A (de)
KR (1) KR100206061B1 (de)
AT (1) ATE138200T1 (de)
AU (1) AU660927B2 (de)
CA (1) CA2079601A1 (de)
DE (1) DE69119591T2 (de)
DK (1) DK0537168T3 (de)
ES (1) ES2090331T3 (de)
FI (1) FI924576A0 (de)
GR (1) GR3020387T3 (de)
WO (1) WO1991016629A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3277211B2 (ja) * 1991-11-12 2002-04-22 プラナ・バイオテクノロジー・リミテッド アルツハイマー病の試験方法と治療方法
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6387697B1 (en) 1998-12-28 2002-05-14 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
EP1248800A2 (de) 1999-11-30 2002-10-16 Corixa Corporation Kompositionen und methoden zur therapie und diagnose von brustkrebs
US20010055596A1 (en) * 2000-03-24 2001-12-27 Meagher Madeleine Joy Compositions and methods for therapy and diagnosis of colon cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
NO861491L (no) * 1985-04-22 1986-10-23 Hybritech Inc Antistoff, fremgangsmaate for dets fremstilling og anvendelse for deteksjon og diagnose av canser.
WO1989000050A1 (en) * 1987-07-02 1989-01-12 Akzo N.V. Antigen recognized by mca 16-88

Also Published As

Publication number Publication date
DE69119591T2 (de) 1996-09-12
GR3020387T3 (en) 1996-09-30
EP0537168B1 (de) 1996-05-15
ES2090331T3 (es) 1996-10-16
WO1991016629A1 (en) 1991-10-31
DE69119591D1 (de) 1996-06-20
FI924576A7 (fi) 1992-10-09
FI924576L (fi) 1992-10-09
DK0537168T3 (da) 1996-09-02
AU660927B2 (en) 1995-07-13
JPH05507470A (ja) 1993-10-28
AU7788491A (en) 1991-11-11
FI924576A0 (fi) 1992-10-09
EP0537168A4 (en) 1993-05-05
CA2079601A1 (en) 1991-10-13
KR100206061B1 (ko) 1999-07-01
EP0537168A1 (de) 1993-04-21

Similar Documents

Publication Publication Date Title
DE69230545D1 (de) Antikörperderivate
KR880700061A (ko) 인체 암종양과 관련된 항원에 대한 단클론성 항체
ES539987A0 (es) Un procedimiento para preparar un anticuerpo monoclonal hu- mano
NO941370L (no) Rekombitope peptider
AU625171B2 (en) Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
ATE138200T1 (de) Das von mca-28a32 erkannte antigen
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
EP0420848A4 (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
NO862097L (no) Monoklonale antistoffer for humane ikke-smaacelle lungekarsinoma.
DE3784364D1 (de) Tumorassoziiertes antigen.
DE69229829D1 (de) Tumorspezifischer monoklonaler antikörper 81av78
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
Fritz IMMUNOLOGICAL INVESTIGATIONS WITH MONOCLONAL ANTIBODY SPECIFIC FOR A LEWIS LUNG TUMOR-ASSOCIATED MEMBRANE ANTIGEN.
FI923418L (fi) Monoklonaalinen vasta-aine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee